We are live on
!
Find out more
PCM
Pentwater Capital Management Portfolio holdings
AUM
$19.3B
1-Year Est. Return
58.13%
This Fund
S&P 500
This Quarter
Est. Return
+13.58%
1 Year Est. Return
+58.13%
3 Year Est. Return
+179.76%
5 Year Est. Return
+629.27%
10 Year Est. Return
+5,046.05%
AUM
$11.9B
AUM Growth
+$2.85B
(+31%)
Cap. Flow
+$2.52B
Cap. Flow
% of AUM
21.15%
Top 10 Holdings %
Top 10 Hldgs %
66.56%
Holding
140
New
48
Increased
33
Reduced
16
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$647M |
| 2 |
K
Kellanova
K
|
+$184M |
| 3 |
Nucor
NUE
|
+$173M |
| 4 |
FYBR
Frontier Communications
FYBR
|
+$161M |
| 5 |
HEES
H&E Equipment Services
HEES
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMAR
Smartsheet Inc.
SMAR
|
+$501M |
| 2 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$473M |
| 3 |
ALTM
Arcadium Lithium plc
ALTM
|
+$141M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$88.2M |
| 5 |
PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
|
+$82.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 11.86% |
| 2 | Materials | 9.38% |
| 3 | Healthcare | 8.13% |
| 4 | Energy | 7.96% |
| 5 | Technology | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
PUT
Invesco S&P 500 Equal Weight ETF
RSP
$99.1B
| $4.33M | 0.04% |
+25,000
| New | +$4.45M |
|
77
PUT
Synopsys
SNPS
$79.7B
| $4.29M | 0.04% |
10,000
-95,000
| -90% | -$46.2M |
|
78
Fortinet
FTNT
$117B
| $3.56M | 0.03% |
+37,000
| New | +$3.75M |
|
|
DEC
79
Diversified Energy Company
DEC
$980M
| $3.24M | 0.03% |
+240,000
| New | +$3.56M |
|
80
Teck Resources
TECK
$32.6B
| $3.1M | 0.03% |
85,000
-195,000
| -70% | -$8.09M |
|
|
81
PUT
Fortinet
FTNT
$117B
| $2.89M | 0.02% |
+30,000
| New | +$3.04M |
|
82
PUT
AMC Entertainment Holdings
AMC
$2.31B
| $2.87M | 0.02% |
+1,000,000
| New | +$3.28M |
|
83
GeneDx Holdings
WGS
$2.3B
| $2.83M | 0.02% |
+32,000
| New | +$2.78M |
|
84
PUT
iShares MSCI Germany ETF
EWG
$1.68B
| $2.78M | 0.02% |
+75,000
| New | +$2.68M |
|
|
85
PUT
GeneDx Holdings
WGS
$2.3B
| $2.21M | 0.02% |
+25,000
| New | +$2.17M |
|
86
PUT
Herc Holdings
HRI
$5.61B
| $2.01M | 0.02% |
+15,000
| New | +$2.56M |
|
87
Broadcom
AVGO
$2.04T
| $2.01M | 0.02% |
+12,000
| New | +$2.54M |
|
|
CHX
88
DELISTED
ChampionX
CHX
| $1.49M | 0.01% |
50,000
-250,000
| -83% | -$7.3M |
|
89
TELA Bio
TELA
$38.9M
| $1.22M | 0.01% |
998,755
-1,245
| -0.1% | -$3.06K |
|
|
TIC
90
TIC Solutions Inc
TIC
$2.2B
| $931K | 0.01% |
+83,749
| New | +$1.01M |
|
|
91
iShares MSCI Germany ETF
EWG
$1.68B
| $927K | 0.01% |
+25,000
| New | +$893K |
|
|
92
PUT
Broadcom
AVGO
$2.04T
| $837K | 0.01% |
+5,000
| New | +$1.06M |
|
93
Viking Holdings
VIK
$47.2B
| $795K | 0.01% |
+20,000
| New | +$922K |
|
|
PARAA
94
DELISTED
Paramount Global Class A
PARAA
| $700K | 0.01% |
30,750
+24,750
| +413% | +$560K |
|
|
PRTC
95
DELISTED
PureTech Health
PRTC
| $664K | 0.01% |
33,560
+9,449
| +39% | +$173K |
|
|
96
CALL
AMC Entertainment Holdings
AMC
$2.31B
| $574K | ﹤0.01% |
+200,000
| New | +$657K |
|
|
CRWV
97
CoreWeave
CRWV
$49.5B
| $556K | ﹤0.01% |
+15,000
| New | +$578K |
|
98
Global Water Resources
GWRS
$219M
| $361K | ﹤0.01% |
+35,000
| New | +$398K |
|
|
VG
99
CALL
Venture Global Inc
VG
$32.9B
| $309K | ﹤0.01% |
+30,000
| New | +$437K |
|
|
ESPR
100
DELISTED
Esperion Therapeutics
ESPR
| $261K | ﹤0.01% |
181,290
| – | – |
|
Similar funds
CS
A
LF
MIM
SPIA
BPA
NAM
Pentwater Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Pentwater Capital Management held 140 positions worth $11.9B, up 31% from $9.06B the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Pentwater Capital Management deployed $2.52B of net new capital in Q1 2025, opening 48 new positions and adding to 33 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 5,190,000 shares worth $685M.
By sector, the portfolio is most concentrated in Industrials at 12% of assets, up from 9.2% a quarter earlier, followed by Materials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $88.2M trimmed.
- Pentwater Capital Management's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 5,190,000 shares worth $685M.
- Pentwater Capital Management added most to Kellanova in Q1 2025, an estimated $184M increase.
- Pentwater Capital Management's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $88.2M.
- Pentwater Capital Management fully exited Smartsheet Inc. in Q1 2025, selling an estimated $501M.
- Pentwater Capital Management's ten largest holdings make up 67% of its $11.9B portfolio in Q1 2025.
- Pentwater Capital Management opened 48 new positions and closed 39 in Q1 2025.
- Pentwater Capital Management's portfolio value rose 31% quarter-over-quarter to $11.9B.
Based on Pentwater Capital Management's 13F filing for Q1 2025, filed 15 May 2025.